Gastric Cancer | Tumor

CURE’s gastric cancer page is a go-to resource for oncology news and updates in the world of gastric cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in gastric cancer.

Popular Minecraft Creator and YouTuber, Technoblade, Dies of Rare Cancer, ‘General Hospital’ Star Discusses Life After Cancer and More

July 1st 2022

From “General Hospital” star Cameron Mathison discussing his cancer experience to Dame Deborah James and Hells Angels founder Sonny Barger dying of the disease, here’s what happened in the cancer space this week.

Hope for a Cancer Cure Is on the Horizon

June 23rd 2022

Recent clinical trial results have given me new hope that one day soon, a cure for all cancers will be found.

FDA Approves Tafinlar Plus Mekinist for Patients With BRAF V600-Mutant Solid Cancers

June 23rd 2022

Tafinlar plus Mekinist is now approved by the Food and Drug Administration to treat adults and children over the age of 6 who have BRAF V600-mutant advanced solid cancers.

As We Enter a New Era of Cancer Treatment, I’m Taking Caution in Headlines Highlighting a Cure

June 14th 2022

Recent headlines have been highlighting a monoclonal antibody that eliminated evidence of disease in patients with rectal cancer, but I believe that findings from the research need to be taken with a few grains of caution.

Country Music Star Toby Keith Announces Stomach Cancer Diagnosis

June 13th 2022

Toby Keith announced in a post on his social media channels that he has been undergoing treatment for stomach cancer since last fall.

Cancer Trial Hopes to Find New Patient Populations That Will Respond to Already-Approved Drugs

May 19th 2022

The Strata PATH trial will use a novel testing strategy to determine if certain patients with solid tumors can benefit from already-approved therapies.

Sheryl Crow Opens Up About Cancer Journey, BBC Radio Host Deborah James Announces She Has Entered Hospice Care and More

May 13th 2022

From Grammy-award winning artist Sheryl Crow discussing her breast cancer journey to a 4-year-old reconnecting with their favorite nurse, here’s what’s happening in the cancer space this week.

Launching of Early-Phase Trial May Mark a ‘Major Milestone’ for Improving Gastric and Pancreatic Cancer Treatment

April 27th 2022

The first patient was dosed in the CLAUDIO-01 trial, analyzing SOTO102 in patients with certain types of gastric and pancreatic cancers.

A Terrible Legacy to Pass Down: Inheriting Lynch Syndrome from an Abusive Parent

March 22nd 2022

My father was an alcoholic, and though he died in 1992, he lives on through my siblings and me because we all inherited a cancer syndrome from him.

Actor William Hurt Dies of Prostate Cancer, Several Cancer Centers Establish Helpline to Connect Ukrainian Patients to Cancer Care and More

March 18th 2022

From two celebrity deaths due to cancer to leading American cancer organizations coming together to help patients with cancer fleeing Ukraine, here’s what’s happening in the cancer space this week.

Clinical Trial Testing Novel Treatment With Standard-of-Care Chemotherapy in Patients With Pancreatic Cancer Expands to New Location

March 16th 2022

Four sites across the United States are enrolling patients with locally advanced or metastatic pancreatic cancer to see if a novel drug combined with standard-of-care chemotherapy bests chemotherapy alone in survival outcomes and responses to treatment.

Patients With Gastric Cancer Who Respond Well to Chemo Before Surgery May Be Able to Skip Post-Operative Chemo

February 1st 2022

Patient sensitivity to chemotherapy prior to surgery could determine if a patient with gastric cancer needs to receive chemo after surgery.

Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival

January 28th 2022

Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.

Adagrasib Confers High Response Rates in Several Gastrointestinal, Pancreatic Tumors

January 26th 2022

Single-agent adagrasib was associated with encouraging treatment responses in patients with previously treated non-colorectal gastrointestinal tumors and pancreatic ductal adenocarcinoma.

Gut Microbiome Makeup May Help Predict Skin-Related Immunotherapy Side Effects in Patients With Gastric Cancer

January 24th 2022

Patients with gastric cancer who present with certain bacteria in their gut were found to be more likely to experience skin-related side effects from Opdivo treatment, research showed.

Enhertu Linked to Sustained Survival Benefit in Gastroesophageal, Gastric Cancer Subset

January 21st 2022

The use of Enhertu was associated with a reduction in the risk of death compared with standard chemotherapy in certain patients with gastroesophageal and gastric cancer.

CYNK-101 Gets FDA Fast Track Designation for HER2-Positive Gastric/GEJ Cancers

January 18th 2022

The FDA will speed up their review of CYNK-101 plus chemotherapy and immune checkpoint inhibitors for the treatment of advanced HER2-postivie gastric or gastroesophageal adenocarcinomas.

It Takes a ‘Huge Clinic Village’ to Create a Dream Cancer Care Team

December 30th 2021

From nurse navigators to surgeons, clinical social workers and more, a patient with cancer often has a village of team members helping them achieve a smooth and successful treatment experience.

‘Don’t Be Afraid to Ask for a Second Opinion,’ Cancer Expert Says

December 22nd 2021

Communication, self-advocacy and having someone in your corner are all critical tools to bring to a cancer care visit, says an expert from MedStar Georgetown University Hospital.

5 Cancer Clinical Trials You May Have Missed

December 18th 2021

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

BOLD-100 Trial Receives FDA Clearance for Treatment of Advanced GI Cancers

November 4th 2021

The Food and Drug Administration gave clearance to Bold Therapeutics for a phase 1b/2a trial examining treatments for advanced GI cancers.

Drug Combo May Prevent Chemo-Induced Nausea and Vomiting in Some Patients

August 31st 2021

Aprepitant, palonosetron and dexamethasone curbed chemotherapy-induced nausea and vomiting in certain women with gastrointestinal cancers who were receiving FOLFIRI or FOLFOX regimens.

FDA Approves Jemperli for Certain Advanced Solid Tumors

August 17th 2021

The indication for the PD-1 blocking antibody now includes adults with mismatch repair-deficient recurrent or advanced disease, adding to the previous indication of endometrial solid tumors.

Staying Aware of Gastric Cancer Risk Factors in Young Adults

August 13th 2021

On behalf of Hope for Stomach Cancer, Dr. Yanghee Woo speaks with CURE® about risk factors for gastric cancer and the alarming rise in cases in young adults.

Looking Forward: Patients With Genetic Mutations Are Empowered to Make Plans

August 6th 2021

Knowing they’ve inherited a genetic mutation for stomach or breast cancer gives patients the power to plan ahead.

FDA’s Approval of Keytruda-Based Regimen for Certain Stomach Cancer Subtypes ‘Really Exciting’ For Patients

July 23rd 2021

The FDA’s recent approval of Keytruda in combination with trastuzumab and chemotherapy in the first-line setting is an exciting change for a group of patients with certain subtypes of stomach cancer, according to an expert.

Treating Cancer as Patients Age

July 20th 2021

As patients aged 65 or older receive a diagnosis of cancer, their treatment course and priorities may differ from their younger counterparts.

New Potential Immunotherapy Treatment Options in Advanced Esophageal Squamous Cell Carcinoma

June 28th 2021

Opdivo was the first PD-1 inhibitor to show durable responses in patients with esophageal squamous cell carcinoma.

Opdivo Combined with Yervoy or Chemo Improves Survival in Unresectable and Advanced Esophageal Cancer

June 5th 2021

Adding Opdivo to treatment with Yervoy or chemotherapy improved survival, compared with chemotherapy alone in patients with unresectable and advanced esophageal cancer.

FDA Approves Opdivo for Adjuvant Treatment of Esophageal and Gastroesophageal Junction Cancer

May 20th 2021

Opdivo was approved by the FDA for use if disease persisted after neoadjuvant chemoradiotherapy in these patients, which is “exciting news,” as patients would typically undergo surveillance when this occurred.